Exagen Inc. (XGN): Net Income
-$19.95M
Year ended 2025-12-31
-$18.92M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$19.95M | n/m | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | -$15.12M | n/m | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | -$23.69M | n/m | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | -$47.39M | n/m | 2024-03-18, From 2022-01-01 |
| 2021-12-31 | -$26.85M | n/m | 2023-03-20, From 2021-01-01 |
| 2020-12-31 | -$16.69M | n/m | 2022-03-22, From 2020-01-01 |
| 2019-12-31 | -$12.04M | n/m | 2021-03-16, From 2019-01-01 |
| 2018-12-31 | -$8.01M | n/a | 2020-03-25, From 2018-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Exagen Inc. (XGN) | 2025-12-31 | -$19.95M | n/m |
| Personalis, Inc. (PSNL) | 2025-12-31 | -$81.27M | n/m |
| Biodesix Inc (BDSX) | 2025-12-31 | -$35.27M | n/m |
| CapForce Inc. (CFOR) | 2025-12-31 | $23.62M | +97.0% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | -$408.35M | n/m |
| American Shared Hospital Services (AMS) | 2025-12-31 | -$1.55M | n/m |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $7.45M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$60.51M | n/m |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | -$24.16M | n/m |
Compare XGN, PSNL, BDSX, CFOR side by side · Screen every company in Services-Medical Laboratories ↗